Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lung Diseases × lorlatinib × 1 year × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 9 Non Small Cell Lung Cancer Metastatic 2 Neuroblastoma 2 Lung Neoplasms 2 Recurrence 1 Neoplasm Metastasis 1 NSCLC 1 Glioma 1 Glioblastoma 1 Ganglioneuroblastoma 1 Diffuse Intrinsic Pontine Glioma 1 Carcinoma 1 Astrocytoma 1 Advanced or Metastatic ROS1-Positive Non-Small Cell Lung Cancer 1 Advanced Non-Small Cell Lung Cancer 1

Interventions

Carboplatin 9 Paclitaxel 5 pembrolizumab 4 Pemetrexed 4 Cisplatin 4 atezolizumab 3 zipalertinib 2 selpercatinib 2 pralsetinib 2 durvalumab 2 Nivolumab 2 Blood Specimen Collection 2 zimberelimab 1 taletrectinib 1 sotorasib 1 sitravatinib 1 sacituzumab govitecan 1 repotrectinib 1 ceralasertib 1 cemiplimab 1 alectinib 1 Vital Signs 1 Tomography, Emission-Computed, Single-Photon 1 Toll-Like Receptor 1 1 Telescopes 1 Radiosurgery 1 Omacor 1 Magnetic Resonance Spectroscopy 1 Ipilimumab 1 Gemcitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡